Brainstorm Cell Therapeutics To Host KOL Webinar On Current Developments In The Treatment Of Amyotrophic Lateral ...
(MENAFN- PR Newswire) NEW YORK, Dec. 2, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI ), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it will host a key opinion …